NCT06426771Completed
Effect of Antimullerian Hormone Levels on the Inflammatory Index, Phytochemical Index and NRF Nutrient Density
Investigation of Dietary Inflammatory Index, Dietary Phytochemical Index and NRF Nutrient Density in Patients With High and Low Antimullerian Hormone Levels
Source: ClinicalTrials.gov · Last updated 19 Nov 2024
Brief summary (registry, in English)
The aim of the study was to calculate the dietary inflammatory index, dietary phytochemical index and NRF nutrient density of the dietary pattern routinely consumed by women and to assess whether there is a difference between PCOS patients with high AMH levels and the group with low AMH levels.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 90 (actual)
- First submitted
- 18 May 2024
- Start date
- 20 Sept 2024
- Primary completion date
- 1 Oct 2024
- Lead sponsor
- Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital
- NCT number
- NCT06426771
What you commit to
- Study type: Observational
- Participants enrolled: 90
- From 20 Sept 2024 to the primary completion date, 1 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Taking medication that affects carbohydrate or fat metabolism (contraceptive pills, metformin, antiepileptic drugs, antipsychotics, statins and fish oil);
- Certain nutritional therapies or hypocaloric diet in the last three months; supplementation with antioxidants, vitamins or minerals;
- Taking medications that can affect fluid balance, such as non-steroidal anti-inflammatory drugs, diuretics, etc.
Other illness
- Hyperandrogenism and/or biochemical hyperandrogenemia due to secondary causes, including congenital adrenal hyperplasia, androgen-secreting tumors, Cushing's syndrome, hyperprolactinemia, thyroid dysfunction, and adrenal disease),
- Pre-existing systemic or psychiatric illnesses
Age
- Age \< 18 and \> 40 years;
Other
- Menopause, pregnancy or breastfeeding in the last 6 months;
- Female patients with implanted pacemakers or defibrillators due to the theoretical possibility of impaired device activity.
Who the study is looking for
- Between the ages of 18 and 40,
- No underlying metabolic disease (type 2 diabetes, hypertension, diagnosed anemia),
- Female patients with AMH levels in our hospital,
- Participants attending the PCOS clinic and under the care of our hospital dietitian will be enrolled in the study.
Age in the registry: 18 years to 40 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Etlik Zübeyde Hanım Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.